Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""You XM"" wg kryterium: Autor


Tytuł:
Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection
Autorzy:
Zhong JH
Ke Y
Zhu SL
Wang L
Luo CP
Gong WF
You XM
Ma L
Xiang BD
Li LQ
Pokaż więcej
Temat:
adefovir dipivoxil
hepatitis B virus
hepatocellular carcinoma
lamivudine
radical resection
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło:
OncoTargets and Therapy, Vol Volume 9, Pp 6897-6907 (2016)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/adefovir-dipivoxil-is-less-expensive-than-lamivudine-and-associated-wi-peer-reviewed-article-OTT; https://doaj.org/toc/1178-6930
Dostęp URL:
https://doaj.org/article/11846793666e4757ad61b691e689d4ac  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Comparison of the specific energies of sinusoidal VCS cutter rings and CCS cutter rings in breaking rock-like materials based on the FEM.
Autorzy:
Zhao JL; School of Mechanical and Aerospace Engineering, Jilin University, 5988 Renmin StreetNanguan District, Changchun, 130000, Jilin Province, China.
Zhu XY; School of Mechanical and Aerospace Engineering, Jilin University, 5988 Renmin StreetNanguan District, Changchun, 130000, Jilin Province, China. .
Zhang H; School of Aeronautical Engineering, Jilin Institute of Chemical Technology, Jilin, 132012, China. .
Xu HL; Northeast Electric Power University, Jilin, 132012, China.
Yang S; School of Mechanical and Aerospace Engineering, Jilin University, 5988 Renmin StreetNanguan District, Changchun, 130000, Jilin Province, China.
Wu P; Changchun Baoze Technology Co., Ltd., Changchun, 130051, China.
You XM; CISDI GROUP Co., Ltd., Chongqing, 401122, China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 07; Vol. 14 (1), pp. 8142. Date of Electronic Publication: 2024 Apr 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort study.
Autorzy:
Huo RR; Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Liao Q; Department of Epidemiology and Biostatistics, School of Public Health, Guangxi Medical University, Shuang Yong Rd. #22, Nanning, 530021, China.
Zhai L; Department of Smart Health Elderly Care Services and Management, School of Nursing, Guangxi Health Science College, Nanning, China.
You XM; Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumour (Guangxi Medical University), Ministry of Education, Nanning, China.; Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumour, Nanning, China.
Zuo YL; Department of Epidemiology and Biostatistics, School of Public Health, Guangxi Medical University, Shuang Yong Rd. #22, Nanning, 530021, China. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jan 13; Vol. 23 (1), pp. 30. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Insulin Resistance*
Stroke*/diagnosis
Stroke*/epidemiology
Adult ; Male ; Middle Aged ; Humans ; Aged ; Female ; Body Mass Index ; Longitudinal Studies ; Prospective Studies ; China/epidemiology ; Glucose ; Triglycerides ; Blood Glucose ; Risk Factors ; Biomarkers
Czasopismo naukowe
Tytuł:
Changes in the triglyceride glucose-body mass index estimate the risk of stroke in middle-aged and older Chinese adults: a nationwide prospective cohort study.
Autorzy:
Huo RR; Department of Experimental Research, Guangxi Medical University Cancer Hospital, He Di Rd. #71, Nanning, 530021, China.
Zhai L; Department of Smart Health Elderly Care Services and Management, School of Nursing, Guangxi Health Science College, Nanning, China.
Liao Q; Department of Epidemiology and Health Statistics, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.
You XM; Department of Experimental Research, Guangxi Medical University Cancer Hospital, He Di Rd. #71, Nanning, 530021, China. .; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumour (Guangxi Medical University), Ministry of Education, Nanning, 530021, China. .; Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumour, Nanning, 530021, China. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Sep 16; Vol. 22 (1), pp. 254. Date of Electronic Publication: 2023 Sep 16.
Typ publikacji:
Journal Article
MeSH Terms:
Body Mass Index*
East Asian People*
Stroke*/blood
Stroke*/diagnosis
Stroke*/epidemiology
Triglycerides*
Blood Glucose*/analysis
Aged ; Female ; Humans ; Male ; Middle Aged ; Glucose/analysis ; Longitudinal Studies ; Prospective Studies ; Risk
Czasopismo naukowe
Tytuł:
Molecular and physiological mechanisms of tea (Camellia sinensis (L.) O. Kuntze) leaf and root in response to nitrogen deficiency.
Autorzy:
Lin ZH; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China. .
Chen CS; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China. .
Zhao SQ; Laixi Bureau of Agriculture and Rural Affairs of Shandong Province, Laixi, 266699, China.
Liu Y; Laixi Bureau of Agriculture and Rural Affairs of Shandong Province, Laixi, 266699, China.
Zhong QS; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Ruan QC; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Chen ZH; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
You XM; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Shan RY; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Li XL; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Zhang YZ; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Pokaż więcej
Źródło:
BMC genomics [BMC Genomics] 2023 Jan 17; Vol. 24 (1), pp. 27. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Camellia sinensis*/metabolism
Chlorophyll A ; Nitrogen/metabolism ; Tea/metabolism ; Plant Leaves/metabolism ; Plant Proteins/genetics ; Plant Proteins/metabolism ; Gene Expression Regulation, Plant
Czasopismo naukowe
Tytuł:
The GC-TOF/MS-based Metabolomic analysis reveals altered metabolic profiles in nitrogen-deficient leaves and roots of tea plants (Camellia sinensis).
Autorzy:
Lin ZH; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China. .
Chen CS; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Zhong QS; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Ruan QC; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Chen ZH; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
You XM; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Shan RY; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Li XL; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fu'an, 355000, China.
Pokaż więcej
Źródło:
BMC plant biology [BMC Plant Biol] 2021 Nov 02; Vol. 21 (1), pp. 506. Date of Electronic Publication: 2021 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
Camellia sinensis/*chemistry
Camellia sinensis/*growth & development
Camellia sinensis/*metabolism
Nitrogen/*deficiency
Nitrogen/*metabolism
Plant Leaves/*metabolism
Plant Roots/*metabolism
Chromatography, Gas ; Crops, Agricultural/chemistry ; Crops, Agricultural/growth & development ; Crops, Agricultural/metabolism ; Mass Spectrometry ; Metabolome ; Metabolomics ; Plant Leaves/chemistry ; Plant Leaves/growth & development ; Plant Roots/chemistry ; Plant Roots/growth & development
Czasopismo naukowe
Tytuł:
Factors associated with resilience among non-local medical workers sent to Wuhan, China during the COVID-19 outbreak.
Autorzy:
Lin J; Nursing Department, Guangxi Medical University Affiliated Tumor Hospital, He Di Rd #71, Nanning, 530021, China.
Ren YH; Nursing Department, Guangxi Medical University Affiliated Tumor Hospital, He Di Rd #71, Nanning, 530021, China.
Gan HJ; Nursing Department, Guangxi Medical University Affiliated Tumor Hospital, He Di Rd #71, Nanning, 530021, China.
Chen Y; Nursing Department, Guangxi Medical University Affiliated Tumor Hospital, He Di Rd #71, Nanning, 530021, China.
Huang YF; Nursing Department, Guangxi Medical University Affiliated Tumor Hospital, He Di Rd #71, Nanning, 530021, China.
You XM; Nursing Department, Guangxi Medical University Affiliated Tumor Hospital, He Di Rd #71, Nanning, 530021, China. You_.
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2020 Aug 24; Vol. 20 (1), pp. 417. Date of Electronic Publication: 2020 Aug 24.
Typ publikacji:
Journal Article
MeSH Terms:
Adaptation, Psychological*
Betacoronavirus*
Resilience, Psychological*
Anxiety/*epidemiology
Coronavirus Infections/*psychology
Depression/*epidemiology
Health Personnel/*psychology
Pneumonia, Viral/*psychology
Adult ; Anxiety/psychology ; COVID-19 ; China/epidemiology ; Coronavirus Infections/therapy ; Cross-Sectional Studies ; Depression/psychology ; Disease Outbreaks ; Female ; Health Personnel/statistics & numerical data ; Humans ; Male ; Pandemics ; Pneumonia, Viral/therapy ; SARS-CoV-2 ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Study on Drug-Drug Interactions Between Chiglitazar, a Novel PPAR Pan-Agonist, and Metformin Hydrochloride in Healthy Subjects.
Autorzy:
Yi L; Drug Clinical Trials Institution, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P.R.China.; Laboratory of Phase I Clinical Study, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P.R.China.
Zhang H; Drug Clinical Trials Institution, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P.R.China.; Laboratory of Phase I Clinical Study, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P.R.China.
Zhang JW; Exploratory Research Department, Shenzhen Chipscreen Biosciences Ltd., BIO-Incubator, Shenzhen Hi-Tech Industrial Park, Guangdong, Shenzhen, China.
You XM; Drug Clinical Trials Institution, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P.R.China.; Laboratory of Phase I Clinical Study, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P.R.China.
Ning ZQ; Exploratory Research Department, Shenzhen Chipscreen Biosciences Ltd., BIO-Incubator, Shenzhen Hi-Tech Industrial Park, Guangdong, Shenzhen, China.
Yu J; Exploratory Research Department, Shenzhen Chipscreen Biosciences Ltd., BIO-Incubator, Shenzhen Hi-Tech Industrial Park, Guangdong, Shenzhen, China.
Qian LF; Drug Clinical Trials Institution, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P.R.China.; Laboratory of Phase I Clinical Study, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P.R.China.
Miao LY; Drug Clinical Trials Institution, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P.R.China.; Laboratory of Phase I Clinical Study, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P.R.China.
Pokaż więcej
Źródło:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 Oct; Vol. 8 (7), pp. 934-941. Date of Electronic Publication: 2019 Feb 27.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Carbazoles/*administration & dosage
Carbazoles/*pharmacokinetics
Metformin/*administration & dosage
Metformin/*pharmacokinetics
Propionates/*administration & dosage
Propionates/*pharmacokinetics
Administration, Oral ; Area Under Curve ; China ; Cross-Over Studies ; Drug Combinations ; Drug Interactions ; Female ; Healthy Volunteers ; Humans ; Male ; Therapeutic Equivalency
Czasopismo naukowe
Tytuł:
Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure.
Autorzy:
Xiang X; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi Cancer Institute, Hospital Oncology School, Guangxi Cancer Center, Nanning, 530021, China.
Qin HG; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi Cancer Institute, Hospital Oncology School, Guangxi Cancer Center, Nanning, 530021, China.
You XM; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi Cancer Institute, Hospital Oncology School, Guangxi Cancer Center, Nanning, 530021, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, 530021, China.
Wang YY; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi Cancer Institute, Hospital Oncology School, Guangxi Cancer Center, Nanning, 530021, China.
Qi LN; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi Cancer Institute, Hospital Oncology School, Guangxi Cancer Center, Nanning, 530021, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, 530021, China.
Ma L; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi Cancer Institute, Hospital Oncology School, Guangxi Cancer Center, Nanning, 530021, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, 530021, China.
Xiang BD; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi Cancer Institute, Hospital Oncology School, Guangxi Cancer Center, Nanning, 530021, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, 530021, China.
Zhong JH; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi Cancer Institute, Hospital Oncology School, Guangxi Cancer Center, Nanning, 530021, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, 530021, China.
Li LQ; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi Cancer Institute, Hospital Oncology School, Guangxi Cancer Center, Nanning, 530021, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, 530021, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2017 Oct; Vol. 6 (10), pp. 2357-2369. Date of Electronic Publication: 2017 Sep 21.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression*
Hepatitis B virus*/genetics
Aflatoxin B1/*adverse effects
Carcinoma, Hepatocellular/*etiology
Hepatitis B/*complications
Liver Neoplasms/*etiology
RNA-Binding Proteins/*genetics
Adult ; Biomarkers ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Female ; Follow-Up Studies ; Hepatitis B/virology ; Humans ; Liver Cirrhosis/etiology ; Liver Cirrhosis/pathology ; Liver Neoplasms/metabolism ; Liver Neoplasms/mortality ; Liver Neoplasms/pathology ; Male ; Middle Aged ; NF-E2-Related Factor 2/metabolism ; Neoplasm Staging ; Neovascularization, Pathologic ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA-Binding Proteins/metabolism ; Signal Transduction ; Survival Analysis ; Tumor Burden
Czasopismo naukowe
Tytuł:
Hepatic resection is superior to transarterial chemoembolization for treating intermediate-stage hepatocellular carcinoma.
Autorzy:
Zhong JH; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
Peng NF; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
You XM; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
Ma L; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
Li LQ; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2017 Jul; Vol. 37 (7), pp. 1083-1084. Date of Electronic Publication: 2016 Nov 19.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Carcinoma, Hepatocellular/*surgery
Liver Neoplasms/*surgery
Chemoembolization, Therapeutic ; Hepatectomy ; Humans ; Retrospective Studies ; Treatment Outcome
Raport
Tytuł:
Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.
Autorzy:
Mo HY; Department of Chemotherapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Liao YY; Department of Nutrition, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
You XM; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
Cucchetti A; Department of Medical and Surgical Sciences, S. Orsola-Malpighi Hospital, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Yuan BH; Department of General Surgery, Yan'An Hospital Affiliated to Kunming Medical University, Kunming, China.
Li RH; Department of General Surgery, Yan'An Hospital Affiliated to Kunming Medical University, Kunming, China.
Zhong JH; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
Li LQ; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Mar 24; Vol. 12 (3), pp. e0174222. Date of Electronic Publication: 2017 Mar 24 (Print Publication: 2017).
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Immunotherapy, Adoptive*
Carcinoma, Hepatocellular/*therapy
Liver Neoplasms/*therapy
Carcinoma, Hepatocellular/pathology ; Humans ; Liver Neoplasms/pathology ; Treatment Outcome
Czasopismo naukowe
Tytuł:
High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.
Autorzy:
Wang YY; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, PR China.; Key Laboratory of Early Prevention and Treatment of Regional High-Incidence-Tumors, Ministry of Education, Nanning 530021, PR China.
Qi LN; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, PR China.; Key Laboratory of Early Prevention and Treatment of Regional High-Incidence-Tumors, Ministry of Education, Nanning 530021, PR China.; Guangxi Cancer Institute, Nanning 530021, PR China.
Zhong JH; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, PR China.; Key Laboratory of Early Prevention and Treatment of Regional High-Incidence-Tumors, Ministry of Education, Nanning 530021, PR China.; Guangxi Cancer Institute, Nanning 530021, PR China.
Qin HG; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, PR China.; Key Laboratory of Early Prevention and Treatment of Regional High-Incidence-Tumors, Ministry of Education, Nanning 530021, PR China.
Ye JZ; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, PR China.; Key Laboratory of Early Prevention and Treatment of Regional High-Incidence-Tumors, Ministry of Education, Nanning 530021, PR China.; Guangxi Cancer Institute, Nanning 530021, PR China.
Lu SD; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, PR China.; Key Laboratory of Early Prevention and Treatment of Regional High-Incidence-Tumors, Ministry of Education, Nanning 530021, PR China.
Ma L; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, PR China.; Key Laboratory of Early Prevention and Treatment of Regional High-Incidence-Tumors, Ministry of Education, Nanning 530021, PR China.; Guangxi Cancer Institute, Nanning 530021, PR China.
Xiang BD; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, PR China.; Key Laboratory of Early Prevention and Treatment of Regional High-Incidence-Tumors, Ministry of Education, Nanning 530021, PR China.; Guangxi Cancer Institute, Nanning 530021, PR China.
Li LQ; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, PR China.; Key Laboratory of Early Prevention and Treatment of Regional High-Incidence-Tumors, Ministry of Education, Nanning 530021, PR China.; Guangxi Cancer Institute, Nanning 530021, PR China.
You XM; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, PR China.; Key Laboratory of Early Prevention and Treatment of Regional High-Incidence-Tumors, Ministry of Education, Nanning 530021, PR China.; Guangxi Cancer Institute, Nanning 530021, PR China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2017 Feb 09; Vol. 7, pp. 42199. Date of Electronic Publication: 2017 Feb 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Aldehyde Reductase/*genetics
Carcinoma, Hepatocellular/*genetics
Liver Neoplasms/*genetics
Neoplasm Recurrence, Local/*genetics
Aged ; Aldo-Keto Reductases ; Biomarkers, Tumor/genetics ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/surgery ; Carcinoma, Hepatocellular/virology ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic ; Hepatectomy/adverse effects ; Hepatitis B virus/pathogenicity ; Humans ; Liver Neoplasms/pathology ; Liver Neoplasms/surgery ; Liver Neoplasms/virology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Neoplasm Recurrence, Local/virology ; Prognosis ; Risk Factors
Czasopismo naukowe
Tytuł:
Carbon dioxide assimilation and photosynthetic electron transport of tea leaves under nitrogen deficiency.
Autorzy:
Lin ZH; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fuan, 355000, China. .
Zhong QS; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fuan, 355000, China.
Chen CS; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fuan, 355000, China.
Ruan QC; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fuan, 355000, China.
Chen ZH; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fuan, 355000, China.
You XM; Tea Research Institute, Fujian Academy of Agricultural Sciences, Fuan, 355000, China.
Pokaż więcej
Źródło:
Botanical studies [Bot Stud] 2016 Dec; Vol. 57 (1), pp. 37. Date of Electronic Publication: 2016 Nov 17.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Is drug-eluting-bead transcatheter arterial chemoembolization (TACE) associated with better tumor response than conventional TACE in a meta-analysis?: Authors' reply.
Autorzy:
Xie ZB; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Wang XB; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Chen J; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Peng YC; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Zhu SL; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Ma L; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Xiang BD; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Gong WF; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
You XM; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Jiang JH; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Li LQ; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Zhong JH; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Pokaż więcej
Źródło:
Hepatology research : the official journal of the Japan Society of Hepatology [Hepatol Res] 2015 Dec; Vol. 45 (12), pp. 1260-1. Date of Electronic Publication: 2015 May 19.
Typ publikacji:
Letter
Opinia redakcyjna
Tytuł:
Systematic review comparing the safety and efficacy of conventional and drug-eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma.
Autorzy:
Xie ZB; Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Wang XB
Peng YC
Zhu SL
Ma L
Xiang BD
Gong WF
Chen J
You XM
Jiang JH
Li LQ
Zhong JH
Pokaż więcej
Źródło:
Hepatology research : the official journal of the Japan Society of Hepatology [Hepatol Res] 2015 Jan; Vol. 45 (2), pp. 190-200. Date of Electronic Publication: 2014 Dec 24.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies